Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05183763 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Medication Adherence Program

Study acronym: MAP
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 1 of 1 entry Show 5 more changesShow less
    • Enrollment closed, study ongoing
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 2 of 8 entries
    • Site details revised at 5 of 5 sites
    • Publications: details revised at 1 of 1 entry
  2. Primary and study completion moved earlier from Jun 30, 2027 to Apr 30, 2027v10
  3. Primary completion date: Apr 30, 2026 to Jun 30, 2027
    • Study completion date: Apr 30, 2027 to Jun 30, 2027
    v9
  4. Collaborators reorderedv8
  5. Eligibility criteria revisedv7
Show 5 earlier versionsHide 5 earlier versions
  1. Site details revised at 1 of 5 sitesv6
  2. Study sites: 4 to 5v5
  3. Primary completion date: Apr 30, 2025 to Apr 30, 2026
    • Study completion date: Apr 30, 2026 to Apr 30, 2027
    v4
  4. Study sites: 1 to 4
    • Eligibility criteria revised
    v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 15, 2022 to Mar 7, 2022
    • Secondary endpoints revised (8)
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tulane University
47 trials monitored
See 8 trials at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
Randomized controlled trial testing the efficacy of the Supporting Tailored Adaptive change and Reinforcement for Medication Adherence Program (STAR-MAP), a health coaching approach that aims to improve antihypertensive medication adherence, blood pressure control, and quality of life. Participants (n=402) \>=40 years old with a diagnosis of hypertension, uncontrolled blood pressure, and low antihypertensive medication adherence will be recruited through a statewide health insurer, Blue Cross Blue Shield of Louisiana, and randomized to receive either interactive health coaching sessions with medication reminder tools (intervention) or medication reminder tools only (control) over one year. Data will be collected from participants at baseline, 6 months, 12 months, and 24 months using questionnaires, physical measurement (height, weight, blood pressure), a computer-based single-category implicit association test, and laboratory analysis of antihypertensive medication urinary metabolites.
Trial Details
NCT Number NCT05183763
Lead Sponsor Tulane University
Collaborators: Ohio State University, Minds at Work, National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Hypertension, Medication Adherence, Behavior and Behavior Mechanisms
Related terms Behavior, Hypertension, Medication Adherence
Enrollment 402 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov